04-9694. National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Conference Call Meeting  

  • Start Preamble

    In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee conference call meeting.

    Name: National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE).

    Time and Date: 2 p.m.-3 p.m., e.s.t., May 13, 2004.

    Place: The conference call will originate at the National Center on Birth Defects and Developmental Disabilities (NCBDDD), in Atlanta, Georgia. Please see SUPPLEMENTARY INFORMATION for details on accessing the conference call.

    Status: Open to the public, limited only by the availability of telephone ports.

    Purpose: The Secretary is authorized by the Public Health Service Act, section 399G, (42 U.S.C. 280f, as added by Public Law 105-392) to establish a National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and surveillance; and (2) to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE.

    Matters to be Discussed: The Task Force will convene via conference call to: (1) Discuss and approve the recent revisions made to the Recommendations on Diagnostic and Referral Criteria for Fetal Alcohol Syndrome, (2) develop new Task Force working groups, and (3) obtain updates on recent motions passed by the Task Force related to the IDEA (Individuals with Disabilities Education Act) reauthorization and an FAS education requirement for teachers.

    Agenda items are subject to change as priorities dictate.

    Supplementary Information: This conference call is scheduled to begin at 2 p.m., eastern standard time. To participate in the conference call, please dial 1-866-453-4348 and enter conference code 602246. You will then be automatically connected to the call.

    Contact Person for More Information: R. Louise Floyd, DSN, RN, Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E-86), Atlanta, Georgia 30333, telephone 404/498-3923, fax 404/498-3550.

    The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR.

    Start Signature

    Dated: April 23, 2004.

    Bill J. Atkinson,

    Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

    End Signature End Preamble

    [FR Doc. 04-9694 Filed 4-28-04; 8:45 am]

    BILLING CODE 4163-18-P

Document Information

Published:
04/29/2004
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
04-9694
Dates:
2 p.m.-3 p.m., e.s.t., May 13, 2004.
Pages:
23508-23508 (1 pages)
PDF File:
04-9694.pdf